Full text
Earnings transcript
Read the complete earnings call transcript.
EXPO
Exponent, Inc.
$57.23
-1.51
(-2.57%)
| Exchange: | NASDAQ |
| Market Cap: | 2.776B |
| Shares Outstanding: | 49.756M |
Delayed data
About The Company
| Sector: | Industrials | |||||
| Industry: | Consulting Services | |||||
| CEO: | Catherine Ford Corrigan | |||||
| Full Time Employees: | 966 | |||||
| Address: |
| |||||
| Website: | https://www.exponent.com |
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm’s activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 536,766 | 558,514 | 582,014 |
| Gross Profit | 135,762 | 142,283 | 145,308 |
| EBITDA | 120,238 | 129,246 | 157,380 |
| Operating Income | 111,322 | 119,557 | 119,787 |
| Net Income | 100,339 | 109,002 | 106,009 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 646,777 | 777,270 | 777,519 |
| Total Liabilities | 290,692 | 356,202 | 387,178 |
| Total Stockholders Equity | 356,085 | 421,068 | 390,341 |
| Total Debt | 28,261 | 81,477 | 82,834 |
| Cash and Cash Equivalents | 187,150 | 258,901 | 221,930 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 127,352 | 144,537 | 131,730 |
| Capital Expenditure | -16,356 | -6,939 | -9,390 |
| Free Cash Flow | 110,996 | 137,598 | 122,340 |
| Net Income | 100,339 | 109,002 | 106,009 |
| Net Change in Cash | 25,692 | 71,751 | -36,971 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 667,442.852 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 667,442.856 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 667,442.854 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 168,399.560 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 168,399.561 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 168,399.561 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 134,608.766 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 146,427.170 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 137,679.750 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 176,211.351 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 176,211.352 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 176,211.351 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 2.700 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 2.860 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 2.630 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 1 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Stable Revenue Growth: Exponent reported a 1% increase in total revenues to $142 million in Q2 2025, as highlighted in the earnings call transcript, reflecting consistent performance despite market challenges. This growth aligns with steady demand in key sectors like energy systems and automotive technologies.
- Strong Operational Metrics: Key financial metrics such as return on equity (ROE TTM) and return on invested capital (ROIC TTM) indicate efficient capital utilization and profitability, positioning EXPO favorably within its industry (specific values to be reviewed from Key Metrics data).
- Innovation Focus: The earnings call emphasized ongoing innovation in energy systems, automotive technologies, and AI applications, showcasing EXPO’s ability to adapt to emerging trends and maintain a competitive edge in its sector.
Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates EXPO intrinsic value between $39.21 – $82.07 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about EXPO valuation
Is Exponent, Inc. (EXPO) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Exponent, Inc. (EXPO) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is EXPO a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether EXPO trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is EXPO’s P/E ratio?
You can see EXPO’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for EXPO?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is EXPO a good long-term investment?
Whether EXPO fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
EXPO
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-2.57
Trading Metrics:
| Open: | 58.71 | Previous Close: | 58.74 | |
| Day Low: | 56.89 | Day High: | 60.36 | |
| Year Low: | 51.91 | Year High: | 81.95 | |
| Price Avg 50: | 62.74 | Price Avg 200: | 68.73 | |
| Volume: | 591074 | Average Volume: | 516134 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freeEXPO full analysis
Welcome to MARKETSNAP’s SWOT analysis for Exponent, a company that might not be on everyone’s radar but definitely deserves a closer look if you’re into long-term wealth-building plays. Today, we’re diving deep into what makes Exponent tick, breaking down their strengths, weaknesses, opportunities, and threats, while sprinkling in some key insights to help you decide if this stock fits your portfolio. So, grab a coffee, let’s get into it, and figure out if Exponent has the juice to power your…
